Literature DB >> 17054109

Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas.

Hidetoshi Eguchi1, Osamu Ishikawa, Hiroaki Ohigashi, Yo Sasaki, Terumasa Yamada, Akihiko Nakaizumi, Hiroyuki Uehara, Akemi Takenaka, Tsutomu Kasugai, Shingi Imaoka.   

Abstract

BACKGROUND: Intraductal papillary mucinous neoplasm (IPMN) is a recently discovered pancreatic tumor that has continuous or discontinuous (skip) lesions. Recent reports suggest a higher frequency of cancer recurrence in the remnant pancreas after surgical resection of IPMN. It is therefore important to precisely detect intraductal cancer extension and skip lesions when resecting IPMN.
METHODS: Both intraoperative histologic examination of the surgical margin and cytologic examination of the pancreatic juice from each pancreatic segment (head, body, or tail) were performed on 43 IPMN patients. In addition to the preoperatively planned resection, 1 or 2 pancreatic segment(s) were additionally resected if the pancreatic juice tested positive in cytology. When a surgical margin was positive but the cytology in the remaining segment was negative, a subsegment (2-cm slice in width) was additionally resected until a negative margin was confirmed.
RESULTS: Twenty-five patients (58%) demonstrated negative results in both histology and cytology obtained from the segment(s) that were not initially intended to be removed. In contrast to the preoperative estimation, 5 patients were found to have a positive surgical margin and negative cytology, 5 patients demonstrated a negative surgical margin and positive cytology, and 8 patients demonstrated a positive surgical margin and positive cytology. Investigations of the resected specimens revealed that 8 patients (19%) had skip lesions in addition to the main lesion. Logistic regression analysis revealed that patients with a dilated main pancreatic duct, or those with cancerous lesions in the main tumors, were at high risk for positive histology and/or cytology.
CONCLUSIONS: Using intraoperative frozen-section histology and pancreatic juice cytology, 18 out of 43 patients in the current study (42%) required additional resection of the pancreas. A necessary and sufficient range of resection should be determined by intraoperative examination. (c) 2006 American Cancer Society.

Entities:  

Mesh:

Year:  2006        PMID: 17054109     DOI: 10.1002/cncr.22301

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

2.  Long-term outcomes after total pancreatectomy: special reference to survivors' living conditions and quality of life.

Authors:  Yusuke Watanabe; Takao Ohtsuka; Taketo Matsunaga; Hideyo Kimura; Koji Tamura; Noboru Ideno; Teppei Aso; Yoshihiro Miyasaka; Junji Ueda; Shunichi Takahata; Hisato Igarashi; Toyoshi Inoguchi; Tetsuhide Ito; Masao Tanaka
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

3.  Role of frozen section assessment for intraductal papillary and mucinous tumor of the pancreas.

Authors:  Alain Sauvanet; Anne Couvelard; Jacques Belghiti
Journal:  World J Gastrointest Surg       Date:  2010-10-27

Review 4.  Controversies in the management of pancreatic IPMN.

Authors:  Masao Tanaka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-01       Impact factor: 46.802

Review 5.  Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment.

Authors:  Robert Grützmann; Marco Niedergethmann; Christian Pilarsky; Günter Klöppel; Hans D Saeger
Journal:  Oncologist       Date:  2010-12-08

Review 6.  Indications to total pancreatectomy for positive neck margin after partial pancreatectomy: a review of a slippery ground.

Authors:  Stefano Crippa; Giulio Belfiori; Domenico Tamburrino; Stefano Partelli; Massimo Falconi
Journal:  Updates Surg       Date:  2021-07-31

7.  Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications.

Authors:  Gian Luca Baiocchi; Nazario Portolani; Guido Missale; Carla Baronchelli; Federico Gheza; Massimiliano Cantù; Luigi Grazioli; Stefano M Giulini
Journal:  World J Surg Oncol       Date:  2010-04-07       Impact factor: 2.754

8.  Efficacy of repeated cytology of pancreatic juice obtained by endoscopic nasopancreatic drainage tube for early diagnosis of pancreatic cancer: a case series including a case of carcinoma in situ.

Authors:  Shin Kato; Moriya Zakimi; Koki Yamada; Kenji Chinen; Tomiaki Kubota; Masayuki Arashiro; Kaoru Kikuchi; Takahiro Murakami; Fumihito Kunishima
Journal:  Clin J Gastroenterol       Date:  2015-07-26

Review 9.  Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management.

Authors:  Claudio Bassi; Michael G Sarr; Keith D Lillemoe; Howard A Reber
Journal:  J Gastrointest Surg       Date:  2007-12-19       Impact factor: 3.452

Review 10.  Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current Perspectives.

Authors:  Ersin Gürkan Dumlu; Derya Karakoç; Arif Özdemir
Journal:  Int Surg       Date:  2015-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.